Moss Genomics Announces Strategic Investment in Genomes.io
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce that on June 18, 2025, it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io Ltd. ("Genomes.io"), a UK-based company focused on secure, user-owned genomic data storage leveraging blockchain infrastructure.Under the terms of the proposed investment, Moss would acquire a non-controlling equity interest in Genomes.io in exchange for 1,111,112...
2025-06-19 8:00 AM EDT
Moss Genomics Launches "Perennial" Genomics Platform, Closes on 130 ETH
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce the public launch of its genomics platform "Perennial", and closing on 130 ETH as part of its ongoing private placement.Public Launch of PerennialMoss is pleased to announce the public launch of its new genomics platform, "Perennial". The platform allows users to upload standard blood test results and receive deep insights personalized to their own...
2025-04-28 7:00 AM EDT
Moss Genomics Announces Listing on the OTC Markets
Vancouver, British Columbia--(Newsfile Corp. - April 11, 2025) - Moss Genomics Inc. (CSE: MOSS) (OTCQB: MSSGF) (FSE: F73) (the "Company" or "Moss") is pleased to announce that its common shares are now listed for trading on the OTC Markets under the ticker MSSGF. This milestone significantly expands Moss's accessibility for U.S.-based investors and enhances overall share liquidity by enabling trading through U.S. broker-dealers.The listing on the OTC Markets is part of Moss's broader strategy to align with global capital markets...
2025-04-11 7:00 AM EDT
Moss Genomics Inc. Announces Leadership Changes
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) ("Moss" or the "Company") is pleased to announce the appointment of Joseph De Pinto to its Board of Directors and Michal "Mickey" Goldstein as its new fractional Chief Financial Officer (CFO).Having served as a co-founder in several blockchain-based companies as well as Barpay, which pioneered digital payments at over 15,000 bars and restaurants over the past decade, Mr. De Pinto brings significant expertise in...
2025-02-26 9:00 AM EST
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to provide an update on its business strategy and the continued development of its genomics-focused initiatives. As the Company advances its product roadmap, it remains committed to leveraging blockchain technology within its genomics platform while maintaining an Ethereum accumulation strategy as part of its treasury management.Moss Genomics is researching and developing technology where users can receive personalized...
2025-02-25 9:00 AM EST
Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000 (the "Offering"). The Offering may close in one or more tranches and is subject to the approval of the Canadian Securities Exchange (the "Exchange"). Additionally, the Company may pay finders' fees in connection...
2025-02-03 7:24 PM EST
Moss Genomics Announces Closing of Private Placement, Acquisition of 160 Ethereum Cryptocurrency (ETH) and Welcomes Hunter Jordan to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - January 31, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce that is has closed its previously announced non-brokered private placement of 2,500,000 common shares (each a "Share") at $0.10 per Share for total gross proceeds of $250,000 (the "Offering"). Concurrently, with the closing of the Offering, the Company announces closing of its acquisition of 160 Ethereum cryptocurrency ("ETH") in consideration for the issuance of 7,840,000 common...
2025-01-31 7:31 PM EST
Moss Genomics Provides Corporate Update and Announces Shift in Business Strategy
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to provide an update on the Company's operations and business strategy.Corporate UpdateFurther to the Company's news release dated December 24, 2024, the Company anticipates closing its non-brokered private placement of 2,500,000 common shares at a price of $0.10 per common share (the "Private Placement") for gross proceeds to the Company of $250,000 near the end of January. Concurrently...
2025-01-24 4:20 PM EST
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to announce that it has successfully listed its shares on the Frankfurt Stock Exchange (FSE) under the ticker symbol F73. This significant milestone marks a pivotal step in the Company's expansion and enhances its global visibility within the European investment community.This listing follows the company's recent accomplishments, including the appointment of Jack Liu as CEO and Director...
2025-01-14 7:00 AM EST
Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEO and Director, Private Placement and Option Grant
Vancouver, British Columbia--(Newsfile Corp. - December 24, 2024) - Moss Genomics Inc. (CSE: MOSS) (the "Company" or "Moss") today announced the appointment of Jack Liu as CEO and a Director of the Company and the launch of its Moss Ethereum treasury division. The Company has entered into an arms-length asset purchase agreement dated December 24, 2024 to acquire 160 ETH for its treasury at a price of CDN$4,900 per ETH in exchange for the issuance of 7,840,000 common shares, at...
2024-12-24 1:00 PM EST
Moss Genomics Inc. Welcomes Martin Bajic to Its Board
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2024) - Moss Genomics Inc. (CSE: MOSS) (the "Company" or "Moss") is pleased to announce that it has appointed Martin Bajic to its Board of Directors. Mr. Bajic replaces Dr. Min Seob Lee, who has resigned as a Director. The Company extends its best wishes to Dr. Lee and thanks him for his service as a member of the Board of Directors.On behalf of the Board of Directors,"Mark Tommasi"DirectorAbout Moss GenomicsMoss...
2024-07-18 4:40 PM EDT
Moss to Launch Revolutionary 90-Second Urine Test and Smartphone App
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), an innovator in the health technology industry, is thrilled to announce that it expects to launch its groundbreaking 90-second urine test and accompanying smartphone app in December 2023. This revolutionary product is set to transform the way individuals monitor their health and detect potential medical conditions, offering quick, accurate, and convenient results at their fingertips.Moss 90-second urine test utilizes cutting-edge technology to...
2023-09-19 8:00 AM EDT
Moss Introduces Diet and Vitamin Reports
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its diet and vitamin reports (the "Reports") which can be ordered directly to your home via our online platform.Up to 80 million genetic variants are analyzed to provide the most insightful information concerning dietary needs and vitamin deficiencies. Our diet reports provide information about celiac, alcohol...
2023-06-16 8:00 AM EDT
Moss Genomics and Proteic Bioscience Sign Memorandum of Understanding
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces signing of a memorandum of understanding ("MOU") with Proteic Bioscience Inc. ("Proteic"). The MOU outlines an essential understanding of a proposed collaboration between Moss and Proteic to design a suite of new protein structures for the development of commercial supplements intended to improve gut health, as well as the...
2023-05-15 8:00 AM EDT
Moss Introduces New Pain and Inflammation Report
Vancouver, British Columbia--(Newsfile Corp. - April 26, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its Pain and Inflammation report which can be ordered directly to your home via the Company's online platform Inflammation is one way our body fights infection, injury, and disease. Sometimes, due to some specific mutations, inflammation can become much more painful. Our Pain & Inflammation...
2023-04-26 8:30 AM EDT
Moss Introduces Cognitive Health Test
Vancouver, British Columbia--(Newsfile Corp. - April 5, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, BC announces the introduction of its Cognitive Health Test which can be ordered directly to your home via the Company's online platform. Moss's Cognitive Health report assesses the genetic markers associated with the ability to clearly think, learn, and remember. This report can be purchased digitally by any customer who has already...
2023-04-05 8:30 AM EDT
Moss Introduces New Gut Microbiome Test
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces the introduction of its Gut Microbiome test which can be ordered directly to your home via the Company's online platform. The gut microbiome is home to trillions of microbes that directly influence a person's mood, how they digest food and how their immune system responds to infections or allergens....
2023-03-28 8:30 AM EDT
Moss Announces Grant of Incentive Stock Options
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces that the Company has granted incentive stock options to certain directors, officers and consultants to acquire 1,320,000 common shares of the Company at a price of C$0.10 per share, vesting immediately.Moss has created an online healthcare and technology platform integrating labs, services and products in a shared economy. Moss...
2023-02-27 7:30 PM EST
Moss to Commence Trading on the Canadian Securities Exchange on January 19, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, is pleased to announce that its common shares have been approved for listing on the Canadian Securities Exchange (the "CSE") and will commence trading at market open on Thursday, January 19, 2023 under the stock ticker symbol "MOSS". Moss provides comprehensive and affordable, at-home genetic and microbiome testing paired...
2023-01-18 7:55 PM EST